Chen Zhao, Sun Xiaowen, Shen Yan, Ni Hong, Chai Shigan, Zou Qichao, Zhang Xiuhua, Zhang Jinzhi
Hubei Collaborative Innovation Center for Advanced Organic Chemical Materials, College of Chemistry and Chemical Engineering, Ministry-of-Education Key Laboratory for the Synthesis and Application of Organic Functional Molecules, Hubei University, Wuhan 430062, China.
Hubei Collaborative Innovation Center for Green Transformation of Bio-Resources, Faculty of Life Science, Hubei University, Wuhan 430062, China.
Mater Sci Eng C Mater Biol Appl. 2015 Apr;49:234-242. doi: 10.1016/j.msec.2014.12.085. Epub 2015 Jan 3.
In this study, a stable antibacterial poly(styrene-co-butyl acrylate) (poly(St-co-BA)) nano-latex was prepared in the presence of a dioctyldimethylammonium chloride (D821)-CTAB mixed surfactant and a novel bis-unsaturated Gemini comonomer (i.e., α,ω-hexanediyl bis(dimethyl methacrylamidopropyl ammonium bromide) (GMAP-6-MAP)) using a feasible and mild semicontinuous technology. The effects of the emulsifiers and GMAP-6-MAP on the properties and antibacterial activities of poly(St-co-BA) coatings were systematically investigated. The results indicate that an optimal monodispersed stable nanoemulsion was obtained with Dw=58.24nm and PDI=0.026, the emulsifier amount was 3.75% (D821/CTAB=4:1), and the GMAP-6-MAP amount was 1.5%. CTAB improved the stabilities and antibacterial activities of the poly(St-co-BA) nanoemulsions. The incorporation of GMAP-6-MAP into poly(St-co-BA) can enhance the antibacterial activity, improve the thermal stability of latex films, as well as the consistency among the chain segments, and decrease the roughness of latex films. This nanoemulsion exhibits effective antibacterial activity with MBCs of 2μg·mL(-1) against Staphylococcus aureus and 16μg·mL(-1) against Escherichia coli. The sterilization rates of the optimized latex film reached 100% against S. aureus and 98.74% against E. coli, which indicated that this latex film could be utilized as an outstanding antibacterial coating.
在本研究中,使用可行且温和的半连续技术,在二辛基二甲基氯化铵(D821)-十六烷基三甲基溴化铵(CTAB)混合表面活性剂和新型双不饱和Gemini共聚单体(即α,ω-己二醇双(二甲基甲基丙烯酰胺丙基溴化铵)(GMAP-6-MAP))存在下制备了稳定的抗菌聚(苯乙烯-共-丙烯酸丁酯)(聚(St-co-BA))纳米胶乳。系统研究了乳化剂和GMAP-6-MAP对聚(St-co-BA)涂层性能和抗菌活性的影响。结果表明,获得了最佳的单分散稳定纳米乳液,其Dw = 58.24nm,PDI = 0.026,乳化剂用量为3.75%(D821/CTAB = 4:1),GMAP-6-MAP用量为1.5%。CTAB提高了聚(St-co-BA)纳米乳液的稳定性和抗菌活性。将GMAP-6-MAP引入聚(St-co-BA)中可增强抗菌活性,提高乳胶膜的热稳定性以及链段间的一致性,并降低乳胶膜的粗糙度。该纳米乳液对金黄色葡萄球菌的最低抑菌浓度(MBC)为2μg·mL(-1),对大肠杆菌的MBC为16μg·mL(-1),表现出有效的抗菌活性。优化后的乳胶膜对金黄色葡萄球菌的杀菌率达到100%,对大肠杆菌的杀菌率达到98.74%,表明该乳胶膜可作为一种优异的抗菌涂层。